Gainers
Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 30 points on Wednesday.
The Dow traded up 0.12% to 32,695.97 while the NASDAQ fell 0.23% to 11,429.16. The S&P 500 also fell, dropping, 0.17% to 3,963.32.
Nerdy (NYSE:NRDY) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.16) by 50 percent. This is a 73.91 percent decrease over losses of $(0.05) per share from the same period